Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONDANSETRON | 8MG | TABLET | Resolved | 2017-03-17 | 2017-10-10 | 3239 |
| ONDANSETRON | 4MG | TABLET | Resolved | 2017-06-05 | 2017-10-10 | 11803 |
| ONDANSETRON | 8MG | TABLET | Resolved | 2017-06-05 | 2017-10-10 | 11806 |
| ONDANSETRON | 4MG | TABLET | Resolved | 2017-09-13 | 2017-10-05 | 21979 |
| ONDANSETRON | 8MG | TABLET | Resolved | 2017-09-13 | 2017-10-05 | 21982 |
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-21 | 2025-07-10 | 240734 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-11-18 | 2025-09-04 | 243274 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-10-06 | 2025-12-04 | 268687 |
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-10-06 | 2025-12-04 | 268690 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-11-28 | 2019-02-06 | 30915 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-12-18 | 2019-02-06 | 33667 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2024-05-28 | 2025-08-12 | 228963 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2024-07-03 | 2025-08-11 | 231993 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2018-03-13 | 2018-05-03 | 42756 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2019-11-29 | 2020-06-03 | 100035 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-06-03 | 109425 |
| PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-04-26 | 2020-03-04 | 82527 |
| PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-11-11 | 2024-11-12 | 242416 |
| PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-09-03 | 2025-10-08 | 266474 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-14 | 2018-10-31 | 58053 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 | ||
| LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73236 | ||
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73239 | ||
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-10-12 | 264958 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-08-12 | 264961 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111527 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-10-27 | 2025-10-28 | 270365 |
| PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79465 |
| PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79468 |
| PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79471 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |